ArticleJournal of thoracic disease2024

Prognostic significance of immunotherapy in postoperative recurrent non-small cell lung cancer without EGFR mutations or ALK rearrangements.

Shunsuke Shigefuku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.